期刊文献+

15-羟基前列腺素脱氢酶抗肿瘤作用的分子机制研究 被引量:1

The Anti-tumor Molecular Mechanism of 15-Hydroxyprostaglandin Dehydrogenase
原文传递
导出
摘要 15-羟基前列腺素脱氢酶是前列腺素生物降解的重要限速酶,多项研究显示其与体内多种肿瘤发生发展关系非常密切,其表达量减低促进肿瘤的发生发展、浸润、转移及肿瘤血管形成。文章就15-羟基前列腺素脱氢酶抗肿瘤的分子机制作一综述。
出处 《中国肿瘤》 CAS 2009年第6期490-492,共3页 China Cancer
  • 相关文献

参考文献17

  • 1郭建友,马悦颖,杨元宵,赵保胜,刘洪斌,李兰芳,郭淑英,霍海如,姜廷良.白细胞介素1β刺激脑微血管内皮细胞内15-羟基前列腺素脱氢酶的经时变化[J].医学研究生学报,2006,19(4):330-333. 被引量:3
  • 2Zhou HP,Yan FX,Tai HH.C-Terminal region of human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase is involved in the interaction with prostaglandin substrates[J].Eur J Biochem,2001,268(12):3368-3374.
  • 3Yan M,Rerko RM,Platzer P,et al.15-Hydroxyprostaglandin dehydrogenase,a COX-2 oncogene antagonist,is a TGF-β-induced suppressor of human gastrointestinal cancers[J].Proc Natl Acad Sci,2004,101(50):17468-17473.
  • 4Ding Y,Tong M,Liu S,et al.NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer[J].Carcinogenesis,2005,26(1):65-72.
  • 5楼俪泓,靖大道,李继坤,吴恺,王兴鹏.15-羟基前列腺素脱氢酶与胃癌发生关系的研究[J].胃肠病学,2006,11(6):340-345. 被引量:5
  • 6Cells JE,Gromov P,Cabezon T,et al.15-PGDH expression alone or in combination with ACSMI defines a subgroup of the apocrine molecular subtype of breast carcinomae[J].Mol Cell Prot,2008,7(10):1795-1809.
  • 7楼俪泓,靖大道,李继坤,吴恺,王兴鹏.胃癌组织中15-羟基前列腺素脱氢酶的表达研究[J].中华医学杂志,2006,86(10):709-711. 被引量:7
  • 8Rao CV,Wang CX,Simi B,et al.Enhancement of experimental colon cancer by genistein[J].Cancer Res,1997,57 (1):3717-3722.
  • 9Myung SJ,Rerko RM,Yan M,et al.15-hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis[J].PNAS,2006,103(32):12098-12102.
  • 10Frenkian M,Segond N,Pidoux E,et al.Indomethacin,a cox inhibitor,enhances 15-PGDH and decreases human tumoral C cells proliferation[J].Prostaglandins Other Lipid Mediat,2001,65(1):11-20.

二级参考文献29

  • 1郭建友,霍海如,赵保胜,刘洪斌,李兰芳,郭淑英,姜廷良.白细胞介素1β刺激脑微血管内皮细胞释放前列腺素E_2的经时变化[J].医学研究生学报,2005,18(6):503-505. 被引量:3
  • 2Quidville V,Segond N,Pidoux E,et al.Tumor growth inhibition by indomethacin in a mouse model of human medullary thyroid cancer:implication of cyclooxygenases and 15-hydroxyprostaglandin dehydrogenase.Endocrinology,2004,145:2561-2571.
  • 3Frenkian M,Segond N,Pidoux E,et al.Indomethacin,a cox inhibitor,enhances 15-PGDH and decreases human tumoral C cells proliferation.Prostaglandins Other Lipid Mediat,2001,65:11-20.
  • 4Ensor CM,Yang JY,Okita RT,et al.Cloning and sequence analysis of the cDNA for human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.J Biol Chem,1990,265:14888-14891.
  • 5Jez JM,Bennett MJ,Schlegel BP,et al.Comparative anatomy of the aldo-keto reductase superfamily.Biochem J,1997,326:625-636.
  • 6Yan M,Rerko RM,Platzer P,et al.15-Hydroxyprostaglandin dehydrogenase,a COX-2 oncogene antagonist,is a TGF-beta-induced suppressor of human gastrointestinal cancers.Proc Natl Acad Sci,2004,101:17468-17473.
  • 7Backlund MG,Mann JR,Holla VR,et al.15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer.J Biol Chem,2005,280:3217-3223.
  • 8Ding Y,Tong M,Liu S,et al.NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer.Carcinogenesis,2005,26:65-72.
  • 9Watanabe H,Jass JR,Sobin LH.Histological typing of oesophageal and gastric tumours.2nd ed.Berlin:Springer,1990.178-183.
  • 10Hermanek P,Hutter RV,Sobin LH,et al.TNM atlas:illustrated guide to the TNM/pTNM,classification of malignant tumors.4th ed.Berlin:Springer Verlag,1997.81-92.

共引文献11

同被引文献14

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部